Iproheptine
Chemical compound
 | |
| Clinical data | |
|---|---|
| Trade names | Metron, Susat |
| Other names | N-Isopropyl-1,5-dimethylhexylamine; N-Isopropyloctodrine |
| Identifiers | |
| |
| CAS Number |
|
| PubChem CID |
|
| ChemSpider |
|
| UNII |
|
| KEGG |
|
| ChEBI |
|
| ChEMBL |
|
| CompTox Dashboard (EPA) |
|
| ECHA InfoCard | 100.034.283  |
| Chemical and physical data | |
| Formula | C11H25N |
| Molar mass | 171.328 g·mol−1 |
| 3D model (JSmol) |
|
| |
InChI
| |
Iproheptine, sold under the brand names Metron and Susat, is a nasal decongestant which has been marketed in Japan.[1][2][3] It is described as a vasoconstrictor and antihistamine.[1][2][3] The drug is available over-the-counter in Japan.[4]
Society and culture
Names
Iproheptine is the generic name of the drug and its INNTooltip International Nonproprietary Name.[1][2] In the case of the hydrochloride salt, its generic name is iproheptine hydrochloride and this is its JANTooltip Japanese Accepted Name.[2] The drug is marketed under the brand names Metron and Susat (both as the hydrochloride salt).[1][2]
See also
References
- ^ a b c d Elks, J. (2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer US. p. 802. ISBN 978-1-4757-2085-3. Retrieved 30 August 2024.
- ^ a b c d e Schweizerischer Apotheker-Verein (2004). Index Nominum: International Drug Directory. Index Nominum: International Drug Directory. Medpharm Scientific Publishers. p. 656. ISBN 978-3-88763-101-7. Retrieved 30 August 2024.
- ^ a b Milne, G.W.A. (2018). Drugs: Synonyms and Properties. Routledge Revivals. Taylor & Francis. p. 286. ISBN 978-1-351-78990-5. Retrieved 30 August 2024.
Iproheptine 13946-02-6 6243 CHAN N-Isopropyl-1,5-dimethylhexylamine. Metron; Metron S. Antihistaminic.
- ^ "KEGG DRUG: Iproheptine Hydrochloride". GenomeNet. Retrieved 30 August 2024.
- v
- t
- e
Decongestants and other nasal preparations (R01)
| Sympathomimetics, plain | |
|---|---|
| Antiallergic agents, excluding corticosteroids | |
| Corticosteroids | |
| Other nasal preparations | |
| Combination products |
Sympathomimetics
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
